First, we analyzed the expression differences of five tyrosine-metabolizing enzymes (TAT, HPD, HGD, GSTZ1, and FAH) in BC compared with normal tissues at the mRNA and protein levels, respectively. This evidence concerns the gene FAH and breast cancer.